TrialPloS one2018

Randomized phase I trial HIV-CORE 003: Depletion of serum amyloid P component and immunogenicity of DNA vaccination against HIV-1.

Nicola J Borthwick et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.